Hualan Biological Engineering Inc. - Laporan Laba Rugi (TTM)

Hualan Biological Engineering Inc.
CN ˙ SZSE ˙ CNE000001JN8
CN¥ 16.83 ↑0.33 (2.00%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Hualan Biological Engineering Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2022
01-01
2022
03-31
2022
06-30
2022
09-30
2023
01-01
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 4,134 5,023 4,969 4,925 5,311 4,436 4,453 5,497 4,677 4,517 4,757 3,753 4,828 5,342 5,249 5,409 4,920 4,379 4,460 4,525
Change (%) 21.50 -1.08 -0.88 7.84 -16.48 0.39 23.43 -14.91 -3.43 5.31 -21.11 28.64 10.65 -1.75 3.06 -9.05 -10.98 1.83 1.46
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 1,368 1,405 1,372 1,361 1,453 1,538 1,563 1,778 1,689 1,699 1,772 1,576 1,700 1,727 1,751 1,906 1,873 1,768 1,799 1,800
Change (%) 2.68 -2.37 -0.75 6.78 5.82 1.60 13.80 -5.05 0.63 4.27 -11.06 7.92 1.56 1.37 8.86 -1.70 -5.61 1.72 0.07
% of Revenue 33.10 27.97 27.60 27.64 27.36 34.67 35.09 32.35 36.10 37.62 37.24 41.99 35.22 32.33 33.35 35.23 38.08 40.38 40.33 39.78
Gross Operating Profit 2,766 3,618 3,598 3,564 3,858 2,898 2,891 3,719 2,989 2,818 2,985 2,177 3,127 3,615 3,498 3,504 3,046 2,611 2,661 2,725
Change (%) 30.81 -0.58 -0.93 8.25 -24.88 -0.25 28.64 -19.62 -5.72 5.94 -27.07 43.64 15.60 -3.24 0.16 -13.05 -14.29 1.91 2.40
% of Revenue 66.90 72.03 72.40 72.36 72.64 65.33 64.91 67.65 63.90 62.38 62.76 58.01 64.78 67.67 66.65 64.77 61.92 59.62 59.67 60.22
SG&A 1,027 1,371 1,344 1,358 1,482 1,022 1,008 1,604 1,258 1,238 1,297 734 1,299 1,479 1,455 1,473 1,210 1,061 1,044 1,064
Change (%) 33.40 -1.94 1.01 9.17 -31.03 -1.38 59.08 -21.55 -1.59 4.77 -43.43 77.05 13.85 -1.63 1.26 -17.86 -12.35 -1.61 1.94
% of Revenue 24.85 27.28 27.05 27.56 27.90 23.04 22.63 29.17 26.90 27.41 27.27 19.55 26.91 27.69 27.72 27.24 24.60 24.22 23.40 23.51
R&D 184 213 235 257 259 254 263 280 284 315 329 310 311 281 276 280 275 333 327 350
Change (%) 15.73 10.16 9.36 0.79 -2.04 3.61 6.52 1.51 10.75 4.39 -5.50 0.04 -9.57 -1.73 1.54 -1.90 21.20 -1.88 7.02
% of Revenue 4.46 4.24 4.73 5.22 4.87 5.72 5.90 5.09 6.08 6.97 6.91 8.27 6.43 5.26 5.26 5.18 5.59 7.61 7.33 7.73
OpEx 2,575 3,026 2,981 3,016 3,263 2,850 2,878 3,712 3,276 3,294 3,438 2,654 3,350 3,531 3,521 3,702 3,404 3,200 3,218 3,255
Change (%) 17.50 -1.49 1.19 8.18 -12.66 0.98 28.97 -11.75 0.55 4.39 -22.80 26.21 5.42 -0.31 5.16 -8.07 -5.97 0.55 1.14
% of Revenue 62.29 60.24 59.99 61.24 61.43 64.24 64.62 67.52 70.03 72.92 72.28 70.73 69.39 66.11 67.08 68.45 69.18 73.08 72.16 71.93
Operating Income 1,559 1,997 1,988 1,909 2,049 1,586 1,576 1,785 1,402 1,223 1,319 1,098 1,478 1,810 1,728 1,707 1,516 1,179 1,241 1,270
Change (%) 28.12 -0.45 -3.98 7.31 -22.57 -0.68 13.31 -21.49 -12.72 7.80 -16.71 34.52 22.52 -4.56 -1.22 -11.19 -22.24 5.32 2.29
% of Revenue 37.71 39.76 40.01 38.76 38.57 35.76 35.38 32.48 29.97 27.08 27.72 29.27 30.61 33.89 32.92 31.55 30.82 26.92 27.84 28.07
Interest Expense -10 -5 -7 -7 -10 -22 -26 -31 -34 -30 -26 -21 -15 -13 -14 -15 -15 -13 -11 -10
Change (%) -51.22 39.72 -5.84 48.41 123.89 21.64 19.13 8.00 -10.98 -14.08 -20.17 -27.65 -12.30 5.79 8.62 0.77 -15.12 -13.63 -8.49
% of Revenue -0.25 -0.10 -0.14 -0.13 -0.18 -0.49 -0.59 -0.57 -0.73 -0.67 -0.55 -0.55 -0.31 -0.25 -0.27 -0.28 -0.31 -0.30 -0.25 -0.23
Net Income 1,284 1,613 1,621 1,559 1,709 1,299 1,277 1,425 1,139 1,076 1,194 1,020 1,243 1,482 1,392 1,395 1,338 1,088 1,139 1,164
Change (%) 25.65 0.50 -3.85 9.66 -24.01 -1.65 11.52 -20.04 -5.52 10.95 -14.58 21.87 19.20 -6.07 0.25 -4.10 -18.69 4.72 2.13
% of Revenue 31.05 32.11 32.62 31.65 32.18 29.28 28.68 25.92 24.35 23.83 25.10 27.18 25.75 27.74 26.52 25.79 27.20 24.84 25.55 25.71

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista